This content is machine translated Antiphospholipid syndrome Preferably anticoagulate with VKA or heparin Antiphospholipid syndrome (APS) is an acquired thrombophilia and is associated with a high risk of venous, arterial or microvascular thrombosis. In APS with thrombotic manifestations, lifelong anticoagulation is generally indicated.…
View Post 7 min This content is machine translated Anticoagulation for atrial fibrillation New ESC guideline has adapted recommendations Atrial fibrillation is the most common persistent cardiac arrhythmia in adults. In the new guidelines for the management of atrial fibrillation, the European Society of Cardiology (ESC) pays particular attention…
View Post 9 min This content is machine translated Screening for atrial fibrillation is not a sure-fire success Oral anticoagulation in AHRE risky and ineffective Anticoagulants increase the risk of bleeding but do not prevent strokes in patients with atrial high rate episodes (AHRE) and without ECG-diagnosed atrial fibrillation. This is the conclusion of the…
View Post 3 min This content is machine translated Anticoagulation for atrial fibrillation Large-scale cohort study compares two DOAKs The results of the prospective observational study showed that in patients over 65 years of age with atrial fibrillation, treatment with rivaroxaban was associated with a significantly increased risk of severe…
View Post 15 min This content is machine translated Therapy of venous occlusions Endovascular interventions – option for patients with more pronounced symptoms Deep vein thrombosis develops in 1/1000 inhabitants of Western Europe per year. In the acute phase, it is critical to prevent the complication of pulmonary artery embolism. This is now… CME-Test
View Post 3 min This content is machine translated Cardiovascular diseases New study data on primary prophylaxis with ASA: carefully weigh benefits and risks Acetylsalicylic acid (ASA) has long been established for the secondary prevention of cardiovascular events. In contrast, ASA administration for primary prevention is controversial. While European experts tend to advise against…
View Post 15 min This content is machine translated Therapy of venous occlusions Endovascular interventions – option for patients with more pronounced symptoms Deep vein thrombosis develops in 1/1000 inhabitants of Western Europe per year. In the acute phase, it is critical to prevent the complication of pulmonary artery embolism. This is now… CME-Test
View Post 5 min This content is machine translated Venous thromboembolism Clinical assessment and anticoagulant therapy – an update. If thromboembolism is not detected and treated in time, life-threatening consequences may result. Validated tests, such as the Wells score and the D-dimer test, can be used to assess the…
View Post 3 min This content is machine translated Direct oral anticoagulants DOAKs in renal insufficiency – GFR tipping the scales Any anticoagulation is a balancing act between thromboembolism and bleeding risk. This is particularly true in the case of chronic kidney dysfunction (CKD). In mild to moderate renal disease, all…
View Post 4 min This content is machine translated Pulmonary embolism Anticoagulate hemodynamically unstable patients even on suspicion Patients with pulmonary embolism require anticoagulation for a period of at least three months. Before starting therapy, several considerations must be addressed: Which anticoagulant is the most appropriate for this…
View Post 12 min This content is machine translated Subsegmental pulmonary emboli In need of therapy or clinically irrelevant? Pulmonary embolism (LE) is grouped together with deep vein thrombosis as venous thromboembolism. Whereas 50 years ago the diagnosis was usually made post-mortem or in the presence of definite clinical… CME-Test
